428 related articles for article (PubMed ID: 22493093)
1. Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.
Satapati S; Sunny NE; Kucejova B; Fu X; He TT; Méndez-Lucas A; Shelton JM; Perales JC; Browning JD; Burgess SC
J Lipid Res; 2012 Jun; 53(6):1080-92. PubMed ID: 22493093
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.
Cappel DA; Deja S; Duarte JAG; Kucejova B; Iñigo M; Fletcher JA; Fu X; Berglund ED; Liu T; Elmquist JK; Hammer S; Mishra P; Browning JD; Burgess SC
Cell Metab; 2019 Jun; 29(6):1291-1305.e8. PubMed ID: 31006591
[TBL] [Abstract][Full Text] [Related]
3. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
Patterson RE; Kalavalapalli S; Williams CM; Nautiyal M; Mathew JT; Martinez J; Reinhard MK; McDougall DJ; Rocca JR; Yost RA; Cusi K; Garrett TJ; Sunny NE
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E484-94. PubMed ID: 26814015
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity.
Rauckhorst AJ; Gray LR; Sheldon RD; Fu X; Pewa AD; Feddersen CR; Dupuy AJ; Gibson-Corley KN; Cox JE; Burgess SC; Taylor EB
Mol Metab; 2017 Nov; 6(11):1468-1479. PubMed ID: 29107293
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
[TBL] [Abstract][Full Text] [Related]
6. Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity.
Kucejova B; Duarte J; Satapati S; Fu X; Ilkayeva O; Newgard CB; Brugarolas J; Burgess SC
Cell Rep; 2016 Jul; 16(2):508-519. PubMed ID: 27346353
[TBL] [Abstract][Full Text] [Related]
7. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
Fletcher JA; Deja S; Satapati S; Fu X; Burgess SC; Browning JD
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31012869
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
9. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.
Sunny NE; Parks EJ; Browning JD; Burgess SC
Cell Metab; 2011 Dec; 14(6):804-10. PubMed ID: 22152305
[TBL] [Abstract][Full Text] [Related]
10. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.
Muyyarikkandy MS; McLeod M; Maguire M; Mahar R; Kattapuram N; Zhang C; Surugihalli C; Muralidaran V; Vavilikolanu K; Mathews CE; Merritt ME; Sunny NE
FASEB J; 2020 Nov; 34(11):14832-14849. PubMed ID: 32918763
[TBL] [Abstract][Full Text] [Related]
11. Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.
Morris EM; Meers GM; Koch LG; Britton SL; Fletcher JA; Fu X; Shankar K; Burgess SC; Ibdah JA; Rector RS; Thyfault JP
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E749-E760. PubMed ID: 27600823
[TBL] [Abstract][Full Text] [Related]
12. Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism.
Satapati S; He T; Inagaki T; Potthoff M; Merritt ME; Esser V; Mangelsdorf DJ; Kliewer SA; Browning JD; Burgess SC
Diabetes; 2008 Aug; 57(8):2012-21. PubMed ID: 18469201
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum-Mitochondria miscommunication in the liver of HFD mice.
Li Y; Tian X; Yu Q; Bao T; Dai C; Jiang L; Niu K; Yang J; Wang S; Wu X
Biomed Pharmacother; 2024 Jun; 175():116682. PubMed ID: 38703507
[TBL] [Abstract][Full Text] [Related]
14. Allyl isothiocyanate ameliorates insulin resistance through the regulation of mitochondrial function.
Ahn J; Lee H; Im SW; Jung CH; Ha TY
J Nutr Biochem; 2014 Oct; 25(10):1026-34. PubMed ID: 25034503
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic fat and glucose oxidation in rats with lipid-induced hepatic insulin resistance.
Alves TC; Befroy DE; Kibbey RG; Kahn M; Codella R; Carvalho RA; Falk Petersen K; Shulman GI
Hepatology; 2011 Apr; 53(4):1175-81. PubMed ID: 21400553
[TBL] [Abstract][Full Text] [Related]
16. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance.
He F; Huang Y; Song Z; Zhou HJ; Zhang H; Perry RJ; Shulman GI; Min W
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33315085
[TBL] [Abstract][Full Text] [Related]
17. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.
Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
J Biol Chem; 2013 Jul; 288(27):19739-49. PubMed ID: 23689508
[TBL] [Abstract][Full Text] [Related]
18. Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.
Dewidar B; Mastrototaro L; Englisch C; Ress C; Granata C; Rohbeck E; Pesta D; Heilmann G; Wolkersdorfer M; Esposito I; Reina Do Fundo M; Zivehe F; Yavas A; Roden M
EBioMedicine; 2023 Aug; 94():104714. PubMed ID: 37454552
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.
Edmunds LR; Xie B; Mills AM; Huckestein BR; Undamatla R; Murali A; Pangburn MM; Martin J; Sipula I; Kaufman BA; Scott I; Jurczak MJ
Mol Metab; 2020 Nov; 41():101051. PubMed ID: 32653576
[TBL] [Abstract][Full Text] [Related]
20. Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice.
Wang Z; Hou L; Huang L; Guo J; Zhou X
Biochem Biophys Res Commun; 2017 Apr; 486(1):116-123. PubMed ID: 28274877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
